688 related articles for article (PubMed ID: 35808814)
1. Association between intestinal microbiota and inflammatory bowel disease.
Zhang Y; Si X; Yang L; Wang H; Sun Y; Liu N
Animal Model Exp Med; 2022 Dec; 5(4):311-322. PubMed ID: 35808814
[TBL] [Abstract][Full Text] [Related]
2. Intestinal Microbiota and miRNA in IBD: A Narrative Review about Discoveries and Perspectives for the Future.
Oliveira ECS; Quaglio AEV; Magro DO; Di Stasi LC; Sassaki LY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108339
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
4. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
[TBL] [Abstract][Full Text] [Related]
5. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
6. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
7. Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn's Disease.
Liu B; Ye D; Yang H; Song J; Sun X; Mao Y; He Z
Front Immunol; 2022; 13():921546. PubMed ID: 35860271
[TBL] [Abstract][Full Text] [Related]
8. The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis.
Zheng J; Sun Q; Zhang J; Ng SC
United European Gastroenterol J; 2022 Dec; 10(10):1091-1102. PubMed ID: 36461896
[TBL] [Abstract][Full Text] [Related]
9. Microbiota and IBD: Current knowledge and future perspectives.
Foppa C; Rizkala T; Repici A; Hassan C; Spinelli A
Dig Liver Dis; 2024 Jun; 56(6):911-922. PubMed ID: 38008696
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
[TBL] [Abstract][Full Text] [Related]
11. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
[TBL] [Abstract][Full Text] [Related]
12. Potential effects of nutrition-induced alteration of gut microbiota on inflammatory bowel disease: A review.
Tian QB; Chen SJ; Xiao LJ; Xie JQ; Zhao HB; Zhang X
J Dig Dis; 2024 Feb; 25(2):78-90. PubMed ID: 38450936
[TBL] [Abstract][Full Text] [Related]
13. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
14. Fundamental crosstalk between circadian rhythm and the intestine in the pathogenesis of inflammatory bowel disease.
Zhang C; Liu X
Clin Res Hepatol Gastroenterol; 2023 Nov; 47(9):102214. PubMed ID: 37748580
[TBL] [Abstract][Full Text] [Related]
15. Emerging pharmacotherapy for inflammatory bowel diseases.
Luo H; Cao G; Luo C; Tan D; Vong CT; Xu Y; Wang S; Lu H; Wang Y; Jing W
Pharmacol Res; 2022 Apr; 178():106146. PubMed ID: 35227890
[TBL] [Abstract][Full Text] [Related]
16. New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
Qi Y; Wu HM; Yang Z; Zhou YF; Jin L; Yang MF; Wang FY
Dig Dis Sci; 2022 Jan; 67(1):42-55. PubMed ID: 33527328
[TBL] [Abstract][Full Text] [Related]
17. Gut mycobiome: The probable determinative role of fungi in IBD patients.
Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.
Recharla N; Geesala R; Shi XZ
Nutrients; 2023 May; 15(10):. PubMed ID: 37242159
[No Abstract] [Full Text] [Related]
19. Microbiome and its relevance to indigenous inflammatory bowel diseases in China.
Han A; Yang M; Chen B; Cao G; Xu J; Meng T; Liu Y; Wang Z; Zhou Y; Xu N; Han W; Sun H; Mei Q; Zhu L; Xiong M
Gene; 2024 May; 909():148257. PubMed ID: 38367851
[TBL] [Abstract][Full Text] [Related]
20. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
